Fairman Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-185
Closed -$1.7K 396
2024
Q3
$1.7K Hold
185
﹤0.01% 293
2024
Q2
$1.81K Hold
185
﹤0.01% 281
2024
Q1
$2.79K Hold
185
﹤0.01% 232
2023
Q4
$3.99K Buy
+185
New +$3.41K ﹤0.01% 210

Other funds holding TDOC

Fairman Group's TDOC Position: Q4 2024 in Review

Fairman Group sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 185 shares — an estimated $1.7K sold.

Fairman Group first reported a position in TDOC in Q4 2023 and held it in 4 quarters. The position peaked at $3.99K in Q4 2023. 380 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

  • Fairman Group reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
  • Fairman Group sold 185 Teladoc Health shares in Q4 2024, an estimated $1.7K.
  • Fairman Group first reported a position in Teladoc Health in Q4 2023 and held it in 4 quarters.
  • Fairman Group's Teladoc Health position peaked at $3.99K in Q4 2023.
  • 380 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Fairman Group's 13F filing for Q4 2024, filed 29 Jan 2025.